Correction: Genetic associations of T cell cancer immune response-related genes with T cell phenotypes and clinical outcomes of early-stage lung cancer

Correction: Genetic associations of T cell cancer immune response-related genes with T cell phenotypes and clinical outcomes of early-stage lung cancer

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-10-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/8/2/e000336corr1.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Genetic associations of T cell cancer immune response-related genes with T cell phenotypes and clinical outcomes of early-stage lung cancer
by: Xifeng Wu, et al.
Published: (2020-10-01)

Identification of CD8+ T Cell-Related Genes: Correlations with Immune Phenotypes and Outcomes of Liver Cancer
by: Qi Pan, et al.
Published: (2021-01-01)

Phenotypic characterization of spatial immune infiltration niches in non-small cell lung cancer
by: Anna Sandström Gerdtsson, et al.
Published: (2023-12-01)

Correction: Complete metabolic response in patients with advanced non-small cell lung cancer with prolonged response to immune checkpoint inhibitor therapy
Published: (2021-06-01)

Correction: Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer
Published: (2021-11-01)

Expression Levels of Some Antioxidant and Epidermal Growth Factor Receptor Genes in Patients with Early-Stage Non-Small Cell Lung Cancer
by: Giuseppe De Palma, et al.
Published: (2010-01-01)

Correction: Apatinib monotherapy for early non-small cell lung cancer: a case report
by: Jiafang Xu, et al.
Published: (2024-11-01)

Correction: Involvement of TRPC Channels in Lung Cancer Cell Differentiation and the Correlation Analysis in Human Non-Small Cell Lung Cancer.
by: Hong-Ni Jiang, et al.
Published: (2024-01-01)

Survival outcomes of surgery and adjuvant chemotherapy in early-stage small cell and large cell lung cancer: a novel focus on tumors less than 1 cm
by: Jorge Raul Vazquez-Urrutia, et al.
Published: (2025-01-01)

Genetic and Biochemical Alterations in Non-Small Cell Lung Cancer
by: Jackie L. Johnson, et al.
Published: (2012-01-01)

Transcriptomics profiling of the non-small cell lung cancer microenvironment across disease stages reveals dual immune cell-type behaviors
by: Marcelo Hurtado, et al.
Published: (2024-10-01)

Programmed Cell Death-Ligand 1 Expression and Clinical Outcomes Among Patients with Resected, Early-Stage Non-Small Cell Lung Cancer: A Real-World Study
by: Parneet K. Cheema, et al.
Published: (2024-10-01)

Immunophenotypic analysis on circulating T cells for early diagnosis of lung cancer
by: Sung-Woo Lee, et al.
Published: (2024-12-01)

Postoperative Lung Function Advantages in Pulmonary Segmentectomy for Early‐Stage Lung Cancer
by: Ernesto Crisafulli, et al.
Published: (2025-01-01)

Real-world treatment patterns and outcomes among unresectable stage III non-small cell lung cancer.
by: Ashwini Arunachalam, et al.
Published: (2024-01-01)

Combination therapy using low‐dose anlotinib and immune checkpoint inhibitors for extensive‐stage small cell lung cancer
by: Han Li, et al.
Published: (2024-12-01)

Mild photothermal therapy for cancer cell modulation: A transformative approach to regulate cancer cell phenotype and enhance therapeutic outcomes
by: Jinyuan Liu, et al.
Published: (2024-12-01)

A two‐phase epigenome‐wide four‐way gene–smoking interaction study of overall survival for early‐stage non‐small cell lung cancer
by: Leyi Chen, et al.
Published: (2025-01-01)

Link of apoptosis level in the primary tumor at early stages of non-small cell lung cancer with efficacy of adjuvant polychemotherapy
by: Kolesnik O.P., et al.
Published: (2013-12-01)

Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis
by: Jeff Clarke, et al.
Published: (2025-02-01)

The immune cells causative role in lung cancer: Mendelian randomization study
by: Qianhui Zhou, et al.
Published: (2024-11-01)

Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy
by: Haochuan Ma, et al.
Published: (2024-11-01)

Rare Cell Population Analysis in Early-Stage Breast Cancer Patients
by: Stefan Schreier, et al.
Published: (2025-01-01)

Liquid biopsy in detecting early non-small cell lung cancer
by: Rafael Rosell, et al.
Published: (2023-09-01)

Study on the Heterogeneity of Cell Subpopulations in Immunotherapy and Immune Checkpoints in Non-small Cell Lung Cancer
by: Yang Yan, et al.
Published: (2024-11-01)

Author Correction: Single-cell and spatial proteo-transcriptomic profiling reveals immune infiltration heterogeneity associated with neuroendocrine features in small cell lung cancer
by: Ying Jin, et al.
Published: (2024-12-01)

The Impact of Age on Treatment Responses in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
by: Gülin Alkan Şen, et al.
Published: (2024-12-01)

Exploring the genetic associations and causal relationships between antibody responses, immune cells, and various types of breast cancer
by: Yang Yang, et al.
Published: (2024-11-01)

The hype around ctDNA guiding an informed perioperative therapeutic strategy in early-stage non-small cell lung cancer
by: Gaia Passarella, et al.
Published: (2025-01-01)

Update on Practical Management of Early-Stage Non-Small Cell Lung Cancer (NSCLC): A Report from the Ontario Forum
by: Parneet K. Cheema, et al.
Published: (2024-11-01)

Utilizing sc-linker to integrate single-cell RNA sequencing and human genetics to identify cell types and driver genes associated with non-small cell lung cancer
by: Yangfan Zhou, et al.
Published: (2025-01-01)

Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity
by: Iuliia Efimova, et al.
Published: (2020-10-01)

An early lung cancer diagnosis model for non-smokers incorporating ct imaging analysis and circulating genetically abnormal cells (CACs)
by: Ran Ni, et al.
Published: (2025-01-01)

Treatment patterns and outcomes in patients with non-small cell lung cancer
by: Florent F. Richy, et al.
Published: (2024-11-01)

Spatially mapping the tumour immune microenvironments of non-small cell lung cancer
by: Lysanne Desharnais, et al.
Published: (2025-02-01)

Antecedent viral immunization and efficacy of immune checkpoint blockade: an extensive serum antibody profile to predict outcomes in non-small cell lung cancer
by: Francois-Xavier Danlos, et al.
Published: (2024-11-01)

Immune-checkpoint inhibitors plus chemotherapy versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer
by: Caicun Zhou, et al.
Published: (2020-10-01)

Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer
by: Wei Zhang, et al.
Published: (2020-10-01)

Mediastinal Staging for Lung Cancer
by: Jacob Gelberg, et al.
Published: (2014-01-01)

Evolution of cystic airspaces lung lesions on immune checkpoint inhibition in non-small cell lung cancer
by: Maurizio Zompatori, et al.
Published: (2020-10-01)